Presbia, which sells surgically implanted lenses to correct age-related vision loss, raised $42 million by offering 4.2 million shares at $10, below the $11 to $13 range. Presbia will list on the NASDAQ under the symbol LENS. Jefferies acted as sole bookrunner on the deal.
